Empowering health through engineering -
- discover earlier, treat better, live happier.
We redesigned biomarker testing because we are devoted to making health data more accessible, no matter the circumstances.
We believe better informed health decisions transforms lives.


The CDC estimates about 40.1 million Americans have diabetes, and 27.6% are undiagnosed.

In the US, about 115.2 million people are predicted to be living with pre-diabetes, which is about 1 in 3 Americans.

Diabetes is the 7th leading cause of death in US.

The International Diabetes Federation predicts about 590 million people are currently living with diabetes, and that 40% of them remain undiagnosed.

By 2050, diabetes is estimated to affect 853 million people, globally. This means 1 in 8 adults will be living with diabetes.
Primary immunodeficiencies (PID) comprises of hundreds of different types of immune system impairment. They are chronic conditions that are characterized by severe, recurrent, or persistent infections. PID may also be referred to as inborn errors of immunity (IEI).
Newborn screening programs have helped with diagnosis in recent years, but PID may not manifest until later in life, where diagnosis becomes more difficult.
It is estimated globally that about 6 million people are affected by a PID and about 70% to 90% remain undiagnosed. It can take years for adults to get the correct medical support needed for diagnosis and treatment.
One important thing to note is that these conditions struggle with getting proper awareness in both public and medical settings.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.